Syngenta Group today announced its financial results for the first half of 2025 (ended June 30), highlighting resilient revenue performance and a significant rebound in profitability, driven by continuous cost control, operational efficiency improvements, and sustained demand for innovative crop protection solutions.
📊 Financial Highlights at a Glance:
-
H1 2025 Revenue: $14.5 billion (flat YoY on reported basis; +2% at constant exchange rates)
-
H1 2025 EBITDA: $2.5 billion (+24% YoY; +29% CER)
-
H1 EBITDA Margin: 17.5%, up 340 basis points from 14.1% in H1 2024
-
Q2 2025 Revenue: $7.2 billion (flat YoY; +1% CER)
-
Q2 2025 EBITDA: $1.1 billion (+32% YoY; +34% CER)
The Group’s enhanced profitability reflects its strategic focus on productivity gains, disciplined cost management, and supply chain optimization. Improved cash flow in the first half further underscores Syngenta’s operational resilience.
🌱 Crop Protection: Innovation Driving Growth
Syngenta’s Crop Protection business recorded $6.4 billion in H1 revenue, up 3% YoY (+7% CER), with strong performance across key regions:
-
Europe: +5% growth, supported by robust bio-solutions demand and normalized inventory levels
-
Asia, Middle East & Africa (ex-China): +9%, driven by new product launches and volume growth
-
China: +9% in H1, with broad-based strength in core technologies and biologicals
-
North America: +10% in H1, though Q2 softened due to seasonal timing
The business secured over 800 new product registrations globally, including breakthrough approvals in Brazil and India for TYMIRIUM® technology and ALTESSIA® herbicide. Syngenta’s bio-solutions segment continued its strong growth trajectory, supported by strategic partnerships and the recent integration of Novartis’ microbial strain library.
A new 22,000 m² bio-production facility in Orangeburg, USA, now operational, will further expand Syngenta’s global capacity for bio-stimulants.
🌾 Seeds: Regional Strength and Pipeline Advances
The Seeds business delivered $2.4 billion in H1 revenue, up 2% YoY (+3% CER), with notable performances in:
-
China: +14% growth in field crops
-
Brazil: +10% growth in field crops
-
Vegetable Seeds: +5% growth
Syngenta advanced field trials for its next-generation herbicide-tolerant soybeans and expanded trait offerings in key markets. In Brazil, the company enhanced its soybean and corn portfolio ahead of the planting season, while initiatives in Indonesia, India, and Vietnam strengthened its position in tropical and hybrid crops.
A new seed health laboratory in the Netherlands will further support quality innovation in vegetable seeds.
🇨🇳 Syngenta Group China: Strategic Shifts Amid Challenges
Syngenta Group China reported revenue of $4.9 billion in H1, down 5% YoY, mainly due to the intentional exit from low-margin businesses. Underlying performance remained robust, with:
-
Seeds: +15%
-
Crop Nutrition: +6%
-
Branded Formulations: +6%
The business launched 12 new certified corn varieties and introduced an AI-powered farming solution—“iMAP”—to support digital and precision agriculture services.
🧪 ADAMA: Stabilization and Strategic Turnaround
ADAMA reported $2.1 billion in H1 revenue (flat YoY; +1% CER), with improving trends in profitability and a return to growth in Q2—the first since Q3 2022.
Regional performances varied:
-
North America: +19%
-
China: +12%
-
Latin America: -9%
The company’s “Fight Forward” transformation initiative continues to optimize its portfolio, with recent launches including Brevis™ SC (fruit thinner) and Upturn® (herbicide) in key markets.
🔮 Outlook
Syngenta expects stable revenue and margin expansion in H2 2025 compared to the lower base of 2024, supported by:
-
Ongoing recovery in the crop protection market
-
Sustained adoption of high-value technologies and biologicals
-
Flexible global manufacturing and tariff-resilient supply chains
The Group remains committed to R&D investment and innovation-led growth, positioning it strongly for long-term sustainable profitability.
